glp 1 chronic fatigue syndrome Multi-'omics of gut microbiome-host interactions in short- and long-term myalgic encephalomyelitis/chronic patients 059 - Ozempic and Wegovy

The principal advantages of microparticulate delivery systems include controlled and sustained drug release, enhanced bioavailability, improved physicochemical stability, and site-specific targeting, all of which contribute to optimized therapeutic outcomes and increased patient adherence [35]

Strey, G

Sanofi's lunsekimig delivered positive Phase II data in asthma hitting its primary endpoint but missed in atopic dermatitis

Dihydroartemisinin prevents dextran sodium sulphate-induced colitisthrough inhibition of the activation of NLRP3 inflammasome and p38 MAPK signaling

Monitoring suicidal patients in primary care using electronic health records

Semaglutide represents the most widely discussed GLP-1 receptor agonist for weight management